– Transparent management and sincere disclosure, attaining fruitful efforts for investors

MEDIPOST announced on April 18 that it was selected as an ‘Excellent Disclosure Corporation’ by the Korea Exchange.

The “Excellent Corporation” is an award given to companies that have contributed to enhancing the transparency of listed companies and creating a climate of sincerity for investors, and the Korea Exchange has been performing the selection since 2012.

MEDIPOST is known for its high praise in terms of the accuracy of disclosures, an understanding of the law enforcement officials, the construction of disclosure infrastructures, voluntary disclosures, and corporate presentations.

With this award, MEDIPOST will receive a wide range of benefits and acts of convenience from the Korea Exchange for the next three years, including the suspension of the designation of unfaithful disclosure corporations, the exemption from the preliminary confirmation of disclosure contents, and annual training exemption.

In addition, the public officials of the “Excellent Corporation” will receive a separate commendation as a “Public Man of Merit”. MEDIPOST is undertaken with various responsibilities, headed by President Hwang Dong Jin, Jeon Gyo Jong, the Head of Finance, and Lee Hwa Young, Head of the IR Team.

In this regard, Lee Hwa Young, head of the IR team of MEDIPOST, said, “We will strive to improve the value of the company through always providing sincere disclosure and transparent and fair information to our investors.”